Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology

Neuro-Oncology

Volumn 13, Issue 6, 2011, Pages 669-679

  Von Bueren, André O ^a   Von Hoff, Katja ^a   Pietsch, Torsten ^b   Gerber, Nicolas U ^c,d   Warmuth Metz, Monika ^c   Deinlein, Frank ^c   Zwiener, Isabella ^e   Faldum, Andreas ^e,f   Fleischhack, Gudrun ^g   Benesch, Martin ^h   Krauss, Juergen ^c   Kuehl, Joachim ^c   Kortmann, Rolf D ⁱ   Rutkowski, Stefan ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

^f UNIVERSITY OF MÜNSTER   (Germany)

^g UNIVERSITY HOSPITAL BONN   (Germany)

^h MEDICAL UNIVERSITY OF GRAZ   (Austria)

ⁱ UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Brain tumor; Chemotherapy; Children; Medulloblastoma; Treatment

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ARTICLE; BLOOD TRANSFUSION; BONE MARROW TOXICITY; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CEREBROSPINAL FLUID INFECTION; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; DIARRHEA; DOSE CALCULATION; DRUG FEVER; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LEUKOENCEPHALOPATHY; LIVER TOXICITY; MALE; MEDULLOBLASTOMA; MUCOSA INFLAMMATION; MULTICENTER STUDY; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SEIZURE; SIDE EFFECT; SINGLE DRUG DOSE; SURVIVAL TIME; TREATMENT CONTRAINDICATION; TREATMENT DURATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CEREBELLAR NEOPLASMS; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; ETOPOSIDE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; LEUCOVORIN; MAGNETIC RESONANCE IMAGING; MALE; MEDULLOBLASTOMA; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; RADIOTHERAPY; REMISSION INDUCTION; SURVIVAL RATE; VINCRISTINE;

EID: 79960010294     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nor025     Document Type: Article

References (34)

1. Kaatsch P, Rickert CH, Kuhl J, Schuz J, Michaelis J. Population-based epidemiologic data on brain tumors in German children. Cancer. 2001;92:3155-3164. (Pubitemid 33136212)
2. Rutkowski S. Current treatment approaches to early childhood medulloblastoma. Expert Rev Neurother. 2006;6:1211-1221. (Pubitemid 44231978)
3. Kellie SJ. Chemotherapy of central nervous system tumours in infants. Childs Nerv Syst. 1999;15:592-612. (Pubitemid 29493586)
4. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol. 1999;17:832-845. (Pubitemid 29109313)
5. Packer RJ, Rood BR, MacDonald TJ. Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg. 2003;39:60-67. (Pubitemid 36829097)
6. Kiltie AE, Lashford LS, Gattamaneni HR. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old. Med Pediatr Oncol. 1997;28:348-354. (Pubitemid 27163672)
7. Rutkowski S, Cohen B, Finlay J, et al. Medulloblastoma in young children. Pediatr Blood Cancer. 2010;54:635-637.
8. Warren KE, Packer RJ. Current approaches to CNS tumors in infants and very young children. Expert Rev Neurother. 2004;4:681-690. (Pubitemid 38890596)
9. Kalifa C, Grill J. The therapy of infantile malignant brain tumors: current status? J Neurooncol. 2005;75:279-285. (Pubitemid 43019483)
10. Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725-1731. (Pubitemid 23170121)
11. Gajjar A, Mulhern RK, Heideman RL, et al. Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. J Clin Oncol. 1994;12:1212-1216. (Pubitemid 24173935)
12. Geyer JR, Zeltzer PM, Boyett JM, et al. Survival of infants with primitive neuroectodermal tumors or malignant ependymomas of the CNS treated with eight drugs in 1 day: a report from the Childrens Cancer Group. J Clin Oncol. 1994;12:1607-1615. (Pubitemid 24244996)
13. Rutkowski S, Bode U, Deinlein F, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005;352:978-986. (Pubitemid 40349500)
14. Chi SN, Gardner SL, Levy AS, et al. Feasibility and response to induction chemotherapy intensified with high-dose methotrexate for young children with newly diagnosed high-risk disseminated medulloblastoma. J Clin Oncol. 2004;22:4881-4887. (Pubitemid 46638611)
15. Mason WP, Grovas A, Halpern S, et al. Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol. 1998;16:210-221. (Pubitemid 28041601)
16. Grill J, Sainte-Rose C, Jouvet A, et al. Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children. Lancet Oncol. 2005;6:573-580. (Pubitemid 41051935)
17. Rutkowski S, Gerber NU, von Hoff K, et al. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy. Neuro Oncol. 2009;11:201-210.
18. Rutkowski S, von Hoff K, Emser A, et al. Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis. J Clin Oncol. 2010;28:4961-4968.
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. WHO Classification of tumours of the central nervous system. Lyon: IARC Press; 2007.
20. Warmuth-Metz M, Bison B, Leykamm S. Neuroradiologic review in pediatric brain tumor studies. Klin Neuroradiol. 2009;19:263-273.
21. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48:1503-1510. (Pubitemid 26035533)
23. Garre ML, Cama A, Bagnasco F, et al. Medulloblastoma variants: agedependent occurrence and relation to Gorlin syndrome-a new clinical perspective. Clin Cancer Res. 2009;15:2463-2471.
24. Giangaspero F, Perilongo G, Fondelli MP, et al. Medulloblastoma with extensive nodularity: a variant with favorable prognosis. J Neurosurg. 1999;91:971-977.
25. Walter AW, Mulhern RK, Gajjar A, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol. 1999;17:3720-3728.
26. Johnston DL, Keene D, Bartels U, et al. Medulloblastoma in children under the age of three years: a retrospective Canadian review. J Neurooncol. 2009;94:51-56.
27. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005;23:7621-7631. (Pubitemid 46291826)
28. Kool M, Koster J, Bunt J, et al. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One. 2008;3:e3088.
29. Pomeroy SL, Tamayo P, Gaasenbeek M, et al. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature. 2002;415:436-442. (Pubitemid 34100955)
30. Thompson MC, Fuller C, Hogg TL, et al. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J Clin Oncol. 2006;24:1924-1931. (Pubitemid 46638992)
31. Northcott PA, Nakahara Y, Wu X, et al. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet. 2009;41:465-472.
32. Northcott PA, Korshunov A, Witt H, et al. Medulloblastoma comprises four distinct molecular variants [published online ahead of print September 7, 2010]. J Clin Oncol. 2010. doi:10.1200/JCO.2009.27.4324.
33. Ater JL, van Eys J, Woo SY, Moore B, 3rd, Copeland DR, Bruner J. MOPP chemotherapy without irradiation as primary postsurgical therapy for brain tumors in infants and young children. J Neurooncol. 1997;32:243-252. (Pubitemid 27077975)
34. Duffner PK, Horowitz ME, Krischer JP, et al. The treatment of malignant brain tumors ininfants and very young children: an update of the Pediatric Oncology Group experience. Neuro-oncol. 1999;1:152-161.